Role of Aromatase Inhibitor to Enhance Ovulation in Poor Responder During Induction With Short Antagonist Protocol in Cases of Intracytoplasmic Sperm Injection

Gynecology & Reproductive Health
doi 10.33425/2639-9342.1031
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SciVision Publishers LLC

Related search

Intracytoplasmic Sperm Injection Outcome in Patient at Risk of Poor Responder Using Mild Ovarian Stimulation Protocol Versus Short Gonadotropin Releasing Hormone Agonist Protocol

The Egyptian Journal of Hospital Medicine
2018English

Role of Endometrial Thickness on Intracytoplasmic Sperm Injection

American Journal of Applied Sciences
Multidisciplinary
2012English

Outcomes in Poor Responders Treated With in Vitro Fertilization/Intracytoplasmic Sperm Injection According to Bologna Criteria

Reproductive Endocrinology
GynecologyEndocrinologyReproductive MedicineObstetricsMetabolismDiabetes
2019English

Intracytoplasmic Sperm Injection ICSI

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
1997English

Comparison Between Intracytoplasmic Sperm Injection and Intracytoplasmic Morphologically Selected Sperm Injection in Oligo-Astheno-Teratozoospermia Patients

Clinical and Experimental Reproductive Medicine
Reproductive Medicine
2014English

In Vitro Fertilisation/Intracytoplasmic Sperm Injection Beyond 2020

BJOG: An International Journal of Obstetrics and Gynaecology
GynecologyObstetrics
2018English

Trends in Use of and Reproductive Outcomes Associated With Intracytoplasmic Sperm Injection

JAMA - Journal of the American Medical Association
Medicine
2015English

Luteal Estradiol Priming Isn't Superior to Conventional GnRH-antagonist Protocol in Poor Responder Patients With Different Anti-Müllerian Hormone Levels

Fertility and Sterility
GynecologyReproductive MedicineObstetrics
2016English

Role of Aromatase Inhibitor in Endometriosis

Journal of Asian Scientific Research
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy